4th International Conference on Acute Myeloid Leukemia : Molecular and Translational Advances in Biology and Treatment

4th International Conference on Acute Myeloid Leukemia : Molecular and Translational Advances in Biology and Treatment is organized by European School of Haematology (ESH) and would be held during Oct 05 - 07, 2017 at Estoril Congress Center, Estoril, Lisboa, Portugal.

The target audience for this medical event are basically for scientists, PhD students, basic scientists, physician-scientists, as well as clinicians with an interest in the field.

This Conference on ACUTE MYELOID LEUKEMIA intends to promote informal interaction and ample discussion between scientists and clinicians working in the field. Scientific presentations by international leaders will provide the current status and a perspective of these exciting developments. In separate sessions results from both basic and clinical research will be presented.

Objectives
- Understand the pathobiology of leukaemia and its development with respect to alterations in hematopoietic stem cells, their microenvironment and altered signal transduction pathways.
- Acquire insight into the possible mechanisms of preleukaemic disorders and genomic instability that predispose to leukemogenesis and predispose also to disease progression.
- Understand about the characterisation of a leukemia stem cell and its relationship to disease development and phenotype.
- Learn about the pathobiologic importance of epigenetic dysregulation in the development of acute myeloid leukemia (eg, methylation, microRNA) and its clinical impact.
- Gain insight into novel therapeutics of acute myeloid leukemia, including knowledge about their mechanisms of action, the current developmental status of various targeted drugs and their promises for future clinical application.